Vanguard Group Inc Castle Biosciences Inc Call Options Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CSTL
# of Institutions
174Shares Held
25.5MCall Options Held
511KPut Options Held
130K-
Black Rock Inc. New York, NY3.04MShares$102 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT2.33MShares$78.3 Million0.27% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.54MShares$51.8 Million0.03% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.22MShares$40.9 Million0.44% of portfolio
-
Portolan Capital Management, LLC Boston, MA1.21MShares$40.7 Million2.33% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $885M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...